abstract |
Provided are novel polypeptide isolate, megakaryocytopoeitin (MKP), together with DNA encoding MKP and recombinant methods for making MKP. Methods for the determination of MKP or its nucleic acid are useful for the diagnosis of certain rare leukemias. Megakaryocytopoeitin is believed to have therapeutic utility in modulating the growth or development of blood cells and their progenitors. |